Antioksidacijski kapacitet jetrenih proteina odojka i njihovih hidrolizata, te njihov učinak in vitro na inhibiciju steatoze by Ruilin Zhang et al.
455October-December 2020 | Vol. 58 | No. 4
Antioxidant Capacity of Proteins and Hydrolysates from the Liver of 
Newborn Piglets, and Their Inhibitory Effects on Steatosis in vitro 
original scientific paper 
ISSN 1330-9862
https://doi.org/10.17113/ftb.58.04.20.6657
Ruilin Zhang ,  
Lasheng Yin ,  
Jian Chen  and 
Xuewu Zhang*
College of Food Science and 
Engineering, South China University 
of Technology, Wshan Road 381, 
510640 Guangzhou, PR China 
Received: 7 February 2020
Accepted: 22 December 2020
*Corresponding author:
Phone/Fax: +86 20 87113848
E-mail: snow_dance@sina.com
SUMMARY
Research background. Non-alcoholic steatohepatitis is a potentially progressive hepat-
ic disorder that can lead to end-stage liver disease and hepatocellular carcinoma. The in-
hibitory effects of proteins and hydrolysates from the liver of newborn piglets on hepatic 
steatosis in oleic acid-induced hepatocellular carcinoma (HepG2) cells were investigated 
in vitro. 
Experimental approach. The extracted proteins from the liver of newborn piglets were 
hydrolysed with papain, pepsin, trypsin and Alcalase. Based on the comparison of differ-
ent enzyme digestion conditions, a protein hydrolysis protocol was established to obtain 
hydrolysates with lipid-lowering effect.
Results and conclusions. Trypsin-digested liver protein hydrolysate from newborn pig-
lets exhibited strong antioxidant activity and good inhibitory effects against lipogenesis 
and cholesterol accumulation in HepG2 cells at the concentration of 150 μg/mL, with a 
triglyceride decrease of (43±3) % and cholesterol decrease of (31±5) %, compared with 
model group induced with 0.75 mM oleic acid. The addition of trypsin-digested liver pro-
tein hydrolysate from newborn piglets (300 μg/mL) decreased alanine aminotransferase 
and aspartate aminotransferase activities and increased superoxide dismutase activity. 
Novelty and scientific contribution. This study demonstrated that the trypsin-digested 
liver protein hydrolysate from newborn piglets has a potential preventive effect against 
non-alcoholic fatty liver disease in its early stage, and a potential use as the modulator of 
lipid overaccumulation in form of food supplements. 
Key words: newborn piglet liver, protein hydrolysates, antioxidant activity, oleic acid, li-
pid accumulation 
INTRODUCTION
Non-alcoholic fatty liver disease (NAFLD) is caused by the lipid accumulation in the 
liver without intaking excessive amounts of alcohol. NAFLD develops from a simple stea-
tosis with the absence of inflammation and non-alcoholic steatohepatitis and can progress 
to liver cirrhosis and malignant hepatic cancer (1,2). Non-alcoholic steatohepatitis is char-
acterized by accumulation of fat, inflammation and injury of liver cells (2). A prevailing 
theory of NAFLD pathogenesis, known as the ’double-hit’ hypothesis, involves both in-
flammation and oxidative stress (3). Generally, lipid overaccumulation is caused by an im-
balance between the uptake (anabolism) and output (catabolism), which causes oxidative 
stress and triggers the overproduction of reactive oxygen species (ROS). As a significant 
pathway in activating the ’second hit’, oxidative stress has an important role in hepatic cell 
damage and dysfunction. There is a subsequent vicious cycle of lipid overaccumulation 
in the fatty liver, resulting in hepatocyte injury and inflammation (3,4). In addition, liver 
injury may induce mitochondrial dysfunction and peroxidation damage, causing steato-
sis. In turn, oxidative stress decrease brings a balance between the production of ROS and 
antioxidant defences, enhancing lipid metabolism and lowering adipose accumulation 
effectively (4). Thus, the reduction of oxidative stress can indirectly regulate fatty acid syn-
thesis and control fatty acid degradation occurring in NAFLD patients.
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Animal products such as bioactive proteins and protein 
hydrolysates have potent liver regeneration effects and may 
stimulate the regeneration of the liver after various types of 
liver injuries. These products include milk protein hydrolysate 
(5), tuna dark muscle protein (6), and pork liver protein hydro-
lysate (7). Additionally, animal liver has long been recognized 
as a source of several nutritional proteins, bioactive polypep-
tides such as hepatocyte growth factor (HGF) and hepatocyte 
stimulator substance (8). HGF is reported as a multifunction-
al cellular growth factor that can be found in a wide variety 
of life cells and tissues, which plays a pivotal role in the liver 
regeneration (9,10). Moreover, hepatic stimulator substance 
and hepatic growth factor regulate the symptoms of NAFLD 
and convey resistance to hepatic injury by protecting mito-
chondrial function (7,11). 
The objective of our work is to study the inhibitory effects 
of liver proteins and their hydrolysates of newborn piglets on 
hepatic steatosis in oleic acid-induced HepG2 cells. In this 
study, to evaluate their lipid-lowering capacity, we investigat-
ed triglyceride (TG) and cholesterol accumulation; the activ-
ities of intracellular biochemical enzymes, alanine ami-
notransferase (ALT), aspartate aminotransferase (AST) and 
superoxide dismutase (SOD); cellular antioxidant activity and 
the inhibition of lipid peroxidation. 
MATERIALS AND METHODS
Material
TSK gel G2000 SWXL and Sephadex G50 (50–150 μm) were 
obtained from Sigma-Aldrich Corp., Merck, St. Louis, MO, 
USA. Pepsin (300 000 U/g), papain (800 000 U/g), trypsin (1:250 
U/g), cholesterol, oleic acid, and bicinchoninic acid protein 
assay kit were obtained from Guangzhou Qiyun Biotech Co., 
Ltd., Guangzhou, PR China. Alcalase 2.4 L (2.4 U/g) and 3- 
-(4,5)-dimethylthiahiazo (-z-y1)-3,5-di-phenytetrazoliumromide 
(MTT) were from Sigma-Aldrich Corp., Merck. Dulbecco’s 
modified Eagle's medium (DMEM), fetal bovine serum, bo-
vine serum albumin (BSA), pravastatin, the alanine ami-
notransferase (ALT), aspartate aminotransferase (AST) and su-
peroxide dismutase (SOD) testing kits were purchased from 
Nanjing Jiancheng Bioengineering Institute, Nanjing, PR Chi-
na. All other reagents were of analytical grade. 
Preparation of proteins from the liver of newborn piglets 
The liver from a newborn pig (5 weeks old) was obtained 
from a market in Shenzhen City, Guangdong Province, PR Chi-
na. The total protein content of the liver was 19.8 %. The liver 
was cut into pieces and washed under running tap water, 
then drained. First, the drained liver pieces were dissolved in 
water at a liver to water ratio of 1:2.8 (m/V). After homogeni-
zation, the liver solution was frozen at −20 °C for 6 h and ul-
trasonicated with 1200DT ultrasonic cell crusher (Biosafer 
Technologies Co., Ltd., Beijing, PR China) at a power of 300 W 
for 15 min. We repeated these processes five times. The 
soluble fraction (extracted liver proteins from newborn piglet 
(LPNP)) were centrifuged using Allegra™ 25R centrifuge (Beck-
man Coulter, Inc., Bremerhaven, Germany) at 8694×g for 
10 min followed by filtration. The supernatants were lyo-
philized by FDU-1200 lyophilizer (Tokyo Rikakikai Co., Ltd., To-
kyo, Japan) and stored at −20 °C. 
Protein hydrolysis and optimization
The extracted LPNP were hydrolysed with four different 
proteases (pepsin, papain, trypsin and Alcalase). To achieve 
this, the LPNP were dissolved in water (m/V=1:3), and the pH, 
temperature and reaction time were adjusted to the optimal 
conditions for each protease. Following the hydrolysis, the 
enzymes were inactivated by heating at 100 °C for 15 min. The 
pepsin-, papain-, trypsin- and Alcalase-digested liver protein 
hydrolysates from newborn piglets (LPH-pepsin, LPH-papain, 
LPH-trypsin and LPH-Alcalase, respectively) were obtained 
by centrifugation at 869×g (Allegra™ 25R centrifuge; Beck-
man Coulter, Inc., Brea, CA, USA) for 10 min, followed by fil-
tration. The supernatants were lyophilized and stored at 
−20 °C. The triglyceride (TG) inhibitory activity of each enzy-
matic hydrolysate (LPH-pepsin, -papain, -trypsin and -Alca-
lase) on oleic acid-induced HepG2 cells in vitro was measured. 
The protein hydrolysis with the highest activity (LPH- 
-trypsin) was selected for optimization. After the initial sin-
gle-factor experiments, based on the Box-Behnken principle, 
a response surface design for three variables (time, temper-
ature and pH) was used to optimize the LPNP hydrolysis pro-
cesses, and TG inhibitory activity was used as the response 
variable (Table S1). The supernatants were obtained by cen-
trifugation at 8694×g for 10 min, then lyophilized and stored 
at −20 °C. 
Determination of antioxidant activities of newborn 
piglet liver proteins and their hydrolysates 
Oxygen radical absorbance capacity (ORAC) assay was 
demonstrated according to Qiu et al. (12). Each newborn pig-
let LPH-pepsin, LPH-papain, LPH-trypsin and LPH-Alcalase 
was mixed with phosphate buffer (75 mM, pH=7.4) to con-
centration of 1 mg/mL. A volume of 20 μL aliquot of each 
sample (LPNP and LPH) was mixed with 120 μL fluorescein 
(c=300 nM) in each well. Plates were then incubated at 37 °C 
for about 30 min in a microtiter plate reader (R164720 Milli-
pore CytoFluor; Millipore Corporation, Bedford, MA, USA). A 
solution of 2,2-azobis (2-amidinopropane) dihydrochloride 
(AAPH, c=80 mM, V=50 μL; Sigma-Aldrich Corp., Merck) was 
added to each well; the plate was incubated under constant 
shaking, and the fluorescence was measured immediately in 
a microtiter plate reader (R164720 Millipore CytoFluor, Milli-
pore Corporation), at 1-minute intervals for 60 min. To eval-
uate the absorbance, the fluorescence was measured at 485 
and 530 nm. The ORAC value was expressed as Trolox equiv-
alents using linear regression in the concentration range of 
6.25–50 μM (13). 
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The radical scavenging activity of DPPH was demonstrat-
ed according to a previously described method (14) with 
slight modification. Briefly, a solution of 0.16 mM DPPH (Nan-
jing Jiancheng Bioengineering Institute) was prepared in ab-
solute methanol. Then, 180 μL of DPPH solution were mixed 
with 20 μL of the samples (LPNP and LPH) in 96-well plates, 
which were incubated at room temperature for 30 min, then 
shaken at 500 rpm thoroughly. The absorbance was read at 
517 nm using a microplate spectrophotometer system (mod-
el 550; Bio-Rad, Hercules, CA, USA). The control group plates 
contained the same volume of DPPH without any extract. 
Molecular mass distributions
The molecular mass distributions of LPNP and LPHs were 
evaluated using HPLC (model LC-10ATvp pump and DGU-12A 
degasser; Thermo Fisher Scientific, Germering, Germany). 
During the experiment, samples were introduced to the gel 
column (TSK gel G2000 SWXL; Tosoh Biosciences, Grove City, 
OH, USA), and the absorbance was monitored at λ=220 nm. 
The flow phase contained phosphate buffer (pH=7.0), and the 
flow velocity was 0.5 mL/min. 
Cytotoxicity of newborn piglet liver proteins  
and their hydrolysates
HepG2 cells were purchased from the Animal Experimen-
tal Center of Sun Yat-Sen University, Guangzhou, PR China. 
These cells were seeded into a 96-well plate (2∙104 cells/well). 
The cells were incubated for 24 h in an incubator (model 
MCO-20AIC; Sanyo Electric Biomedical Co., Osaka, Japan) at 
5 % CO2 and 37 °C. Then, the medium was removed, and each 
well was washed once with phosphate-buffered saline (PBS). 
The medium was replaced with serum-free DMEM containing 
different concentrations of LPNP and LPHs, and the cultures 
were incubated for 24 h. The cells were washed twice with 
PBS. Then, 200 μL of 0.5 mg/mL MTT were added to each well 
and incubated for 4 h. Then, the MTT solution was removed, 
and 150 mL dimethyl sulfoxide were added. The absorbance 
was read at 490 nm using a microplate reader (Thermo Fisher 
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Inhibitory effect on oleic acid-induced 
fatty liver model in vitro
HepG2 cells were incubated for 24 h in a 6-well plate at a 
density of 2∙105 cells/well. The regular medium was removed 
from the wells, and they were washed once with PBS. The cells 
were incubated with a medium containing 0.75 mM bovine 
serum albumin (BSA) with oleic acid for another 24 h. New-
born piglet LPNP and LPH were respectively added to the 
6-well plate and incubated for 24 h. Cells cultured in media 
with only 1 % BSA or 100 mg/L pravastatin were used as the 
control and positive sample, respectively. 
Measurement of intracellular triglyceride 
concentration and oil red O staining
The intracellular TG concentration was measured using 
triglyceride assay kit (Beijing BHKT Clinical Reagent Co., Ltd. 
Beijing, PR China), and the total protein concentration was 
measured with a bicinchoninic acid protein assay kit. Intra-
cellular TG concentration was expressed in micrograms of TG 
per milligram of cellular protein. Oil red O staining was ap-
plied to measure the degree of preadipocyte differentiation 
according to a previous study (15). 
Measurement of intracellular cholesterol levels
After 24 h of cultivation, the HepG2 cells were harvested 
and lysed, then a 2:1 chlorine/methanol solution was added. 
After being left for 12 h, the cholesterol content of the liquid 
was measured. We used qualitative and quantitative chroma-
tographic analysis to analyse cholesterol mass fractions. In-
tracellular compounds were investigated with an HPLC sys-
tem with a diode array detector (model SPD-M10Avp; 
Shimadzu, Kyoto, Japan). The solvent methanol was used for 
the mobile phase. The cytochylema from each group was in-
jected into the column using a 20-μL loop valve. The flow rate 
was set to 1.0 mL/min, and absorbance was measured at 210 
nm using UV spectrophotometer (model SPD-M10Avp; Shi-
madzu). Components were tentatively identified by compar-
ing their retention times (tR) with the authentic standards at 

























where At=12.5 min is the peak area of the sample at tR=12.5 min. 
Measurement of intracellular SOD, ALT and AST activities
SOD, ALT and AST activities were measured using enzy-
matic kits according to the manufacturer’s instructions (Nan-
jing Jiancheng Bioengineering Institute). The total protein 
levels were tested with a bicinchoninic acid assay kit. 
Statistical analysis
Data were presented as mean value±standard deviation 
of triple replicates. The significance of the differences (p<0.05, 
p<0.01) between the two groups was assessed using the 
paired t-test. All statistical analyses were performed using 
SPSS v. 26.0 (16). 
RESULTS AND DISCUSSION
Cytotoxicity of newborn piglet liver proteins and their 
hydrolysates, and their effects on cell proliferation and 
TG accumulation in oleic acid-induced hepatic steatosis
In this study, through a combination of freeze-thawing 
and ultrasonication, 91.9 % (m/m) of crude proteins were 
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extracted from newborn piglet liver. Different concentrations 
of LPNP, LPH-pepsin, LPH-papain, LPH-trypsin and LPH-Alca-
lase were incubated with HepG2 cells to determine their cy-
totoxicity (Fig. 1a). The results show that the five samples did 
not significantly reduce the cell viability over a period of 24 
h at 300 μg/mL (p>0.05). Safe doses of 50–300 μg/mL were 
used to determine TG accumulation in the HepG2 cells. The 
data indicated that LPH-trypsin was the most efficient sup-
pressor of TG accumulation in the hepatocyte (Fig. 1b), with 
a maximum TG decrease of 40.3 % at 150 μg/mL. LPH-pepsin 
and LPNP caused the maximum TG decrease of 30.7 and 
32.2 %, respectively (Fig. 1b). TG decrease rate of LPH-trypsin 
was lower than that of the pravastatin group (100 mg/L, 51.2 %). 
According to the literature, the hepatic TG decrease capacity 
of LPH-trypsin is weaker than of bioactive small molecules 
(polyphenols and flavonoids) (14). Liu et al. (15) suggested that 
blueberry phenolic acid is efficient in inhibiting TG accumu-
lation in HepG2 cells, and maximal TG decrease was 58.6 %, 
when the concentration was 100 μg/mL. Alshammari et al. (17) 
showed that nimbolide from Azadirachta indica successfully 
reduces intracellular cholesterol by 47.3 % relative to the con-
trol. Nevertheless, relative to other protein or polypeptides, 
LPH-trypsin has a strong capacity of decreasing hepatic TG 
accumulation. 
Protein hydrolysis optimization
Trypsin hydrolysis was conducted on the extracted pro-
teins. The single-factor experiment indicated that the opti-
mum conditions for trypsin hydrolysis included a pH=8.5, a 
temperature of 50 °C and a reaction time of 7 h. Subsequent-
ly, a response surface design was performed with the three 
variables, temperature, pH and the reaction time, using TG 
concentration (in nmol per mg of protein) as the objective 
function (Fig. 2). Using regression analysis, we obtained the 
following response equation: 
 
b(TG)=130.23+2.28 A+0.99 B+1.73 C+0.40 A B+
+0.29 A C+1.20
⋅ ⋅ ⋅ ⋅ ⋅
⋅ ⋅ ⋅B C+7.53 A +3.73 B +3.86 C2 2 2⋅ ⋅ ⋅ ⋅
 /3/
According to the sum of squares presented in Table 1, the 
contribution of the three factors to the degree of hydrolysis 
can be placed in the following order: temperature>pH>reac-
tion time. The optimal hydrolysis conditions (minimum TG 
accumulation) were determined to be a pH=8.4, temperature 
of 49.27 °C and reaction time of 6.91 h. Experimental verifica-
tion under the conditions of pH=8.5, temperature of 49 °C, 
and a reaction time of 7 h determined the TG concentration 
in protein to be 129.8 nmol/mg, close to the theoretical value 
of 128.8 nmol/mg. The lipid-lowering ability of the optimized 
hydrolysates was roughly improved by 3.2 %, compared with 
unoptimized LPH-trypsin (40.3 %, γ=150 μg/mL). 
Molecular mass distribution of newborn piglet 
liver proteins and their hydrolysates
As shown in Table 2, the fraction of peptides in LPH- 
-trypsin with molecular mass<3000 Da was up to 85.07 %, 
which was the highest among the LPNP and LPHs, with the 
peptides in the molecular mass range <1000 and 1000–3000 
Da being 38.14 and 46.93 %, respectively. The fraction of pep-
tides in newborn piglet LPNP with molecular mass<3000 Da 
was 65.51 %, with the peptides of <1000 Da at 39.29 % and 
1000–3000 Da at 26.22 %. Additionally, the fraction of large 
peptides (>5000 Da) of LPNP was up to 20.7 %. Combined 
with previous results, low molecular mass peptides of LPH- 
-trypsin may contribute to its antioxidant and lipid lowering 
abilities. Moreover, other reports have also proposed a small 
molecular peptide with good bioactivity (18,19). 
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Fig. 1. The results show: a) cytotoxic effect of newborn piglet liver 
proteins and their hydrolysates on HepG2 cells. Cell viability was de-
termined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazoli-
um bromide (MTT) assay and is expressed as a percentage of control 
cells with sample-free DMEM medium, b) effect of exposure to 0.75 
mmol/L oleic acid on intracellular triglyceride (TG) accumulation 
and inhibitory effect of newborn piglet liver proteins and their hy-
drolysates at γ=300 μg/mL on TG overaccumulation in HepG2 cells. 
*p<0.05 relative to the model (0.75 mM oleic acid-induced cell). All 
tests were performed in triplicate, and the results are presented as 
mean value±S.D. LPNP=liver proteins of newborn piglet, LPH-pep-
sin=pepsin-digested PLP hydrolysate, PLH-trypsin=trypsin-digested 
LPNP hydrolysate, LPH-Alcalase=Alcalase-digested LPNP hydroly-
sate, BSA=bovine serum albumin
Food Technol. Biotechnol. 58 (4) 455–464 (2020)
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Antioxidant activities of newborn piglet 
liver proteins and their hydrolysates
Newborn piglet LPH-trypsin exhibited higher radical scav-
enging activity than the other hydrolysates. DPPH radical scav-
enging capacity of LPH-trypsin (IC50=7.2 mg/mL) was higher 
than of LPH-pepsin (IC50=8.2 mg/mL) and LPNP (IC50=9.2 mg/
mL) (data not shown). The investigation of the oxygen radical 
absorbance capacity (ORAC), expressed as Trolox equivalents, 
showed that the samples (LPNP, LPH-pepsin and LPH-trypsin) 
had different capacities. LPH-trypsin had the highest ORAC ac-
tivity ((594±2) μM/g) among the hydrolysates. LPH-pepsin pro-
duced the second-highest ORAC activity ((427±2) μM/g), 
whereas LPNP had the lowest ((254±4) μM/g) (p<0.05). LPH- 
-trypsin showed significantly (p<0.05) higher reducing power 
than the other extracts (data not shown). These results suggest 
that LPH-trypsin has a strong oxygen radical scavenging (ROS) 
activity, which might contribute to its lipid-lowering effect. 
Domínguez-Pérez et al. (20) showed that hepatocyte growth 
factor reduces free cholesterol-mediated lipotoxicity by inhib-
iting overproduction of ROS, compared with normal cells. Xie 
et al. (21) also pointed out that dihydromyricetin reduces oleic 
acid-induced lipid accumulation in L02 and HepG2 cells by in-
hibiting lipogenesis and oxidative stress. Vidyashankar et al. 
(22) reported that quercetin effectively ameliorates NAFLD 
symptoms by decreasing triacyl glycerol accumulation and in-
creasing cellular antioxidants in oleic acid-induced hepatic ste-
atosis in HepG2 cells. 
Inhibitory effects of the liver proteins and their hydrolysates 
on fat accumulation in steatotic HepG2 cells
In HepG2 cells, the effectiveness of LPNP, LPH-pepsin and 
LPH-trypsin in inhibiting TG and fat overaccumulation was 
evaluated (Fig. 3). The results showed that LPNP and LPH-pep-
sin obtained the maximum TG decrease rate of roughly 30.7 
and 32.21 %, respectively (Fig. 3a and Fig. 3b). LPH-trypsin 
was effective in suppressing TG accumulation in steatotic 
Table 1. Analysis of variance (ANOVA) of the liver proteins from newborn piglets hydrolysed with trypsin
Parameter Sum of squares df Mean square F value p-value
Model 475.9101 9 52.8789 43.66345 <0.0001
temperature/°C (A) 41.67845 1 41.67845 34.41495 0.0006
t/h (B) 7.860613 1 7.860613 6.490707 0.0382
pH (C) 23.83951 1 23.83951 19.68489 0.0030
AB 0.6561 1 0.6561 0.541758 0.4856
AC 0.3364 1 0.3364 0.277774 0.6144
BC 5.784025 1 5.784025 4.776016 0.0651
A2 238.5346 1 238.5346 196.9641 <0.0001
B2 58.7142 1 58.7142 48.48181 0.0002
C2 62.71078 1 62.71078 51.78188 0.0002
Residual 8.477395 7 1.211056
Lack of fit 6.328275 3 2.109425 3.926119 0.1098
Pure error 2.14912 4 0.53728
Cor total 484.3875 16





Fig. 2. Effects of cross-interaction among the three parameters on 
the degree of hydrolysis of trypsin: a) pH values and temperatures, 
b) pH values and enzyme-to-substrate ratio, and c) temperature and 
enzyme-to-substrate ratio
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cells, with a maximum TG decrease rate of 43.3 % at a concen-
tration of 150 μg/mL (Fig. 3c), which was weaker than blue-
berry phenolic acid (58.6 %, γ=100 μg/mL) (15). To investigate 
whether newborn piglet liver proteins and their hydrolysates 
affect oleic acid-induced cellular steatosis, a simple qualita-
tive method to analyse the amount of stored intracellular li-
pid droplets was performed using oil red O staining. The cells 
in the normal group exhibited irregular polygons, clear edg-
es and fewer red-stained lipid droplets (Fig. 4). After treat-
ment with 0.75 mM oleic acid, HepG2 cells began to appear 
circular and intracellular lipid droplets became larger with a 
deeper red colour. The number and size of the lipid droplets 
significantly reduced after the treatment with newborn pig-
let LPNP and LPH, relative to those of the model group. At 
concentration of 150 μg/mL, the intracellular lipid droplets of 
cells treated with LPH-trypsin became smaller with a slightly 
less intense red colour. In concurrence with the TG accumu-
lation data, LPH-trypsin showed significantly most effective 
inhibition of TG (p<0.05) in HepG2 cells at concentration of 
150 μg/mL. 
Effects of newborn piglet liver proteins and their 
hydrolysates on cholesterol secretion in HepG2 cells 
Cholesterol peaks were observed at absorbance of 210 
nm and trR=12.5 min. As shown in Fig. 5, the amount of cho-
lesterol significantly decreased in HepG2 cells treated with 
liver proteins and their hydrolysates compared with the mod-
el group. LPH-trypsin was the most efficient at suppressing 
cholesterol accumulation, with a maximum decrease rate of 
30.5 % at a concentration of 150 μg/mL. 
Effects of newborn piglet liver proteins and 
their hydrolysates on SOD in HepG2 cells
Superoxide dismutase (SOD) was measured in the cell to 
investigate whether the lipid-decreasing effect of liver proteins 
and their hydrolysates in vitro is related to their antioxidant 
capacity. Fig. 6 shows that the total SOD activity was inhibit-
ed in the cells treated with 0.75 mM oleic acid compared with 
the activity in the control group. However, SOD activity in-
creased after the treatment with newborn piglet liver pro-
teins and their hydrolysates. According to the obtained re-
sults, SOD activity significantly increased by 23.53 % (p<0.05) 
after treatment with 300 μg/mL LPH-trypsin (Fig. 6c), com-
pared with the model cells. 
Effect of newborn piglet liver proteins and their 
hydrolysates on ALT and AST production in HepG2 cells
In general, high ALT and AST levels in the blood are indi-
cators of hepatitis. Specifically, ALT and AST are indicators of 
hepatic cell inflammation. Therefore, in the cell model, ALT 
and AST release assays were used to evaluate the progress of 
NAFLD. Oleic acid increases AST and ALT levels in steatotic 


















































































Fig. 3. Effect of exposure to 0.75 mmol/L oleic acid on intracellu-
lar triglyceride (TG) accumulation. Inhibitory effect of: a) LPNP, b) 
LPH-pepsin, and c) LPH-trypsin at 75, 150 and 300 μg/mL on TG over-
accumulation in HepG2 cells; #p<0.05 and ##p<0.01 relative to the 
control sample, *p<0.05 and **p<0.01 relative to the model sample. 
Abbreviations as in Fig. 1 
Table 2. Molecular mass distributions of piglet liver proteins and their 




>10000 13.352 3.953 1.162
10000-5000 7.343 4.945 1.503
5000-3000 13.479 11.379 12.26
3000-1000 39.29 42.292 46.93
<1000 26.22 37.02 38.14
LPNP=liver proteins from newborn piglets, LPH-pepsin=pepsin- 
-digested LPNP hydrolysate, LPH-trypsin=trypsin-digested LPNP 
hydrolysate
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group (p<0.05), suggesting that HepG2 cells treated with 
oleic acid exhibited oxidative stress. After the treatment with 
LPH-trypsin, ALT and AST activities reduced significantly (23 
and 15.2 %, respectively), relative to the model group (data 
not shown). There is no significant difference between the 
AST and ALT activities in the groups treated with 300 μg/mL 
LPH-trypsin and in the control group. These results show that 
the biological properties of LPH-trypsin increased the levels 
of AST and ALT activity at 150–300 μg/mL in HepG2 cells 
(p<0.05). Previous literature reported that bioactive mole-
cules effectively reduce fat accumulation in hepatocytes by 
renewing AST and ALT activities (7–9). Yin et al. (23) showed 
that Hugan Qingzhi tablets exert a preventive effect against 
hepatic steatosis by enhancing AST and ALT enzyme activi-
ties. Shimizu et al. (7) showed that consumption of pork liver 
protein hydrolysate decreases the body mass and inhibits he-
patic lipogenesis in rats significantly. The mechanisms of the 
4 
Fig. 1. 























Fig. 5. HPLC analysis of the effect of exposure to 0.75 mmol/L oleic 
acid and treatment with LPNP, LPH-pepsin and LPH-trypsin on intra-
cellular cholesterol accumulation in HepG2 cells. Pure cholesterol 
used as standard with a peak at 210 nm after tR=12.5 min. Abbrevi-
ations as in Fig. 1
Fig. 4. Oil red O staining of corresponding fractions (LPNP, LPH-pepsin and LPH-trypsin) at 75, 150 and 300 μg/mL, indicating triglyceride (TG) 
overaccumulation in HepG2 cells. Original magnification was 200×, scale bars represent 75 μm. Abbreviations as in Fig. 1
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liver protein or protein hydrolysate inhibition of TG synthesis 
in hepatocytes and its relationship to their antioxidant prop-
erties remain to be elucidated. 
To study the lipid-lowering effects and antioxidant activ-
ities of newborn piglet liver proteins and their hydrolysates 
using in vitro experiments, HepG2 cells were incubated with 
a mixture of oleic acid to induce cellular steatosis. The num-
ber of lipid droplets and the levels of TG and cholesterol in-
creased significantly in the cells treated with 0.75 mM oleic 
acid, which indicates that the steatosis model in vitro had 
been established successfully. Obviously, 0.75 mM oleic acid 
causes oxidative stress in hepatocytes, and it has been well 
documented that hepatic antioxidant systems are significant-
ly decreased in several chronic liver diseases (20,22). Newborn 
piglet liver proteins and their hydrolysates reduced the size 
of lipid droplets, the intracellular TG, and cholesterol content 
significantly. The involvement of classical intracellular ROS 
scavengers, such as SOD, is of fundamental importance in the 
development of therapeutical approaches to oxidation-based 
liver pathologies. It is known that SOD plays an important role 
in hepatocyte defence against ROS, free radicals and electro-
philic metabolites (23–25). Therefore, the present data showed 
that newborn piglet liver proteins and their hydrolysates pro-
tect hepatocytes against oxidative stress and ameliorate in-
tracellular TG, cholesterol and lipid overaccumulation. Com-
pared with oleic acid-induced model, LPH-trypsin caused a 
decrease of 43.3 % TG in oleic acid-induced HepG2 cells at 
150 mg/mL, which was little lower than that of hypolipidae-
mic drug pravastatin group (γ=100 mg/L, 51.2 %). The capac-
ity of LPH-trypsin to decrease TG was slightly lower than of 
small bioactive molecules (polyphenols, flavonoids and phe-
nolic acids) (14,15), and higher than in other types of protein 
hydrolysate (5,7). These results indicate that LPH-trypsin in-
hibits well the TG accumulation in HepG2 cells.
Literature demonstrated that NAFLD is a multifactorial 
disease resulting from a complex interaction of environment, 
enzymes and metabolism (3,23,26). The protective effects of 
bioactive molecules are induced against oleic acid-induced 
hepatic steatosis by regulation of intracellular AST and ALT in 
vitro (23). Moreover, the experimental results show that AST 
and ALT activities significantly decreased in the LPH-trypsin 
group. The data indicated that 300 μg/mL LPH-trypsin pos-
sess a strong hepatoprotective effect because aminotrans-
ferase is generally considered to be an indicator of hepato-
cyte injury. Hence, LPH-trypsin reduced the progression of 
hepatic steatosis because of its antioxidant properties, which 
can protect mitochondria from peroxidation damage, inhib-
it TG overaccumulation and recover normal metabolism. 
Oleic acid can increase lipid, TG and cholesterol accumu-
lation and induce mitochondrial dysfunction, which increase 
steatosis in the cells. Newborn piglet liver proteins and their 
hydrolysates reduced these symptoms, exerting inhibitory 
effects against the overaccumulation of TG in hepatic cells. In 
addition, liver proteins and hydrolysates effectively weaken 
intracellular oxidative stress at high concentrations, while in-
effectively preventing TG overaccumulation (26,27). Newborn 
piglet liver proteins and their hydrolysates are a mixture of 
hepatocyte growth factor, hepatocyte stimulator substance 
and various free amino acids, which confer resistance to he-
patic injury and oxidative stress by improving mitochondrial 
functions. 
However, the lipid-decreasing mechanisms of LPH-tryp-
sin require further investigation. We aim to focus in the future 
on the cellular energy regulation in NAFLD and signalling 
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Fig. 6. Effect of exposure to 0.75 mmol/L oleic acid on the intracel-
lular antioxidant enzyme superoxide dismutase (SOD) in fatty cells 
and inhibitory effect of: a) LPNP, b) LPH-pepsin and c) LPH-trypsin on 
SOD activities in HepG2 cells; #p<0.05 relative to the control sample; 
*p<0.05 relative to the model sample. Abbreviations as in Fig. 1
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using model animals are needed to confirm the present find-
ings, especially the lipid-decreasing effects of LPH-trypsin in 
the alimentary tract and liver. 
CONCLUSIONS
The results of the study clearly suggested that the liver 
proteins and their hydrolysates of newborn piglets have the 
potential to scavenge free radicals and prevent hepatic stea-
tosis. The triglyceride (TG) inhibitory capability was different 
in the proteins and their hydrolysates. Generally, the proteins 
and all of the hydrolysates showed good inhibitory activity 
against triglyceride and cholesterol accumulation, and 
trypsin-digested hydrolysate was the most effective lipid ac-
cumulation inhibitor with a maximum TG reduction of 43.3 %. 
Therefore, liver proteins and their hydrolysates of newborn 
piglets exert good protective effects to reduce the risk of 
non-alcoholic fatty liver disease. 
CONFLICT OF INTEREST
The authors report no conflicts of interest. 
ACKNOWLEDGEMENTS
This research was funded by Guangzhou Major Project of 
Industry-University Collaborative Innovation (201704020024). 
AUTHORS’ CONTRIBUTION 
X. Zhang was responsible for the design of this project 
and final version of the manuscript. R. Zhang contributed to 
the project experiments, data acquisition or and analysis. L. 
Yin and J. Chen drafted and revised the article. 
SUPPLEMENTARY MATERIALS
All supplementary materials are available at: www.ftb.
com.hr. 
ORCID ID
R. Zhang  https://orcid.org/0000-0002-1678-1812
J. Chen  https://orcid.org/0000-0003-3477-6045
L. Yin  https://orcid.org/0000-0003-1466-9779
X. Zhang  https://orcid.org/0000-0001-9870-0686
REFERENCES
 1.  Musso G, Gambino R, Cassader M. Recent insights into he-
patic lipid metabolism in non-alcoholic fatty liver disease 
(NAFLD). Progr Lipid Res. 2009;48(1):1–26. 
https://doi.org/10.1016/j.plipres.2008.08.001
 2.  Te Sligte K, Bourass I, Sels JP, Driessen A, Stockbrügger RW, 
Koek GH. Non-alcoholic steatohepatitis: Review of a grow-
ing medical problem. Eur J Intern Med. 2004;15(1):P10–21. 
https://doi.org/10.1016/j.ejim.2003.12.008
 3.  Periasamy S, Chien SP, Chang PC, Hsu DZ, Liu MY. Sesame 
oil mitigates nutritional steatohepatitis via attenuation of 
oxidative stress and inflammation: A tale of two-hit hypo-
thesis. J Nutr Biochem. 2014;25(2):232–40.
https://doi.org/10.1016/j.jnutbio.2013.10.013
 4.  Rossi SP, Windschüttl S, Matzkin ME, Rey-Ares V, Terradas 
C, Ponzio R, et al. Reactive oxygen species (ROS) production 
triggered by prostaglandin D2 (PGD2) regulates lactate de-
hydrogenase (LDH) expression/activity in TM4 Sertoli cells. 
Mol Cell Endocrinol. 2016;434:154–65.
https://doi.org/10.1016/j.mce.2016.06.021
 5.  Moura CS, Lollo PCB, Morato PN, Risso EM, Amaya-Farfan 
J. Functional effects of milk bioactive peptides on skeletal 
muscle of rats. Food Res Int. 2016;84:18–25.
https://doi.org/10.1016/j.foodres.2016.03.001
 6.  Maeda H, Hosomi R, Fukuda M, Ikeda Y, Yoshida M, Fukun-
aga K. Dietary tuna dark muscle protein attenuates hepat-
ic steatosis and increases serum high-density lipoprotein 
cholesterol in obese type-2 diabetic/obese KK-Ay mice. J 
Food Sci. 2017;82(5):1231–8.
https://doi.org/10.1111/1750-3841.13711
 7.  Shimizu M, Tanabe S, Morimatsu F, Nagao K, Yanagita T, 
Kato N, Nishimura T. Consumption of pork-liver protein hy-
drolysate reduces body fat in Otsuka Long-Evans Tokush-
ima fatty rats by suppressing hepatic lipogenesis. Biosci 
Biotechnol Biochem. 2006;70(1):112–8.
https://doi.org/10.1271/bbb.70.112
 8.  Xiao F, Zhang J, Zhang C, An W. Hepatic stimulator sub-
stance inhibits calcium overflow through the mitochon-
dria-associated membrane compartment during nonalco-
holic steatohepatitis. Lab Invest. 2017;97:289–301.
https://doi.org/10.1038/labinvest.2016.139
 9.  Libetta C, Esposito P, Martinelli C, Grosjean F, Gregorini M, 
Rampino T, Dal Canton A. Hepatocyte growth factor (HGF) 
and hemodialysis: Physiopathology and clinical implica-
tions. Clin Exp Nephrol. 2016;20:371–8.
https://doi.org/10.1007/s10157-015-1211-2
10.  Ziegler KM, Considine RV, True E, Swartz-Basile DA, Pitt HA, 
Zyromski NJ. Adipocytes enhance murine pancreatic can-
cer growth via a hepatocyte growth factor (HGF)-mediated 
mechanism. Int J Surg. 2016;28:179–84.
https://doi.org/10.1016/j.ijsu.2016.03.002
11.  Tahara M, Matsumoto K, Nukiwa T, Nakamura T. Hepato-
cyte growth factor leads to recovery from alcohol-induced 
fatty liver in rats. J Clin Invest. 1999;103(3):313–20.
https://doi.org/10.1172/JCI4433
12.  Qiu Y, Liu Q, Beta T. Antioxidant properties of commercial 
wild rice and analysis of soluble and insoluble phenolic ac-
ids. Food Chem. 2010;121(1):140–7.
https://doi.org/10.1016/j.foodchem.2009.12.021
13.  Liu L, Zhang R, Deng Y, Zhang Y, Xiao J, Huang F, et al. Fer-
mentation and complex enzyme hydrolysis enhance total 
R. ZHANG et al.: Antioxidant Capacity of Liver Proteins and Hydrolysates from Newborn Piglets
October-December 2020 | Vol. 58 | No. 4464
phenolics and antioxidant activity of aqueous solution 
from rice bran pretreated by steaming with α-amylase. 
Food Chem. 2017;221:636–43.
https://doi.org/10.1016/j.foodchem.2016.11.126
14.  Kondo S, Tsuda K, Muto N, Ueda JE. Antioxidative activity 
of apple skin or flesh extracts associated with fruit devel-
opment on selected apple cultivars. Sci Hortic. 2002;96(1–
4):177–85.
https://doi.org/10.1016/S0304-4238(02)00127-9
15.  Liu Y, Wang D, Zhang D, Lv Y, Wei Y, Wu W, et al. Inhibitory 
effect of blueberry polyphenolic compounds on oleic ac-
id-induced hepatic steatosis in vitro. J Agric Food Chem. 
2011;59(22):12254–63.
https://doi.org/10.1021/jf203136j
16.  SPSS software, v. 26.0, SPSS Inc., Chicago, IL, USA; 2019. 
Available from: https://spss-64bits.en.softonic.com/.
17.  Alshammari GM, Balakrishnan A, Chinnasamy T. Nimbolide 
attenuate the lipid accumulation, oxidative stress and an-
tioxidant in primary hepatocytes. Mol Biol Rep. 2017;44: 
463–74.
https://doi.org/10.1007/s11033-017-4132-1
18.  Pampanin DM, Larssen E, Provan F, Sivertsvik M, Ruoff P, 
Sydnes MO. Detection of small bioactive peptides from At-
lantic herring (Clupea harengus L.). Peptides. 2012;34(2):423–
6.
https://doi.org/10.1016/j.peptides.2012.02.005
19.  Xia E, Zhai L, Huang Z, Liang H, Yang H, Song G, et al. Opti-
mization and identification of antioxidant peptide from 
underutilized Dunaliella salina protein: Extraction, in vit-
ro gastrointestinal digestion, and fractionation. BioMed 
Res Int. 2019;2019:Article ID 6424651.
https://doi.org/10.1155/2019/6424651
20.  Domínguez-Pérez M, Nuño-Lámbarri N, Clavijo-Cornejo D, 
Luna-López A, Souza V, Bucio L, et al. Hepatocyte growth 
factor reduces free cholesterol-mediated lipotoxicity in pri-
mary hepatocytes by countering oxidative stress. Oxid 
Med Cell Longev. 2016;2016:Article ID 7960386.
https://doi.org/10.1155/2016/7960386
21.  Xie C, Chen Z, Zhang C, Xu X, Jin J, Zhan W, et al. Dihydro-
myricetin ameliorates oleic acid-induced lipid accumula-
tion in L02 and HepG2 cells by inhibiting lipogenesis and 
oxidative stress. Life Sci. 2016;157:131–9.
https://doi.org/10.1016/j.lfs.2016.06.001
22.  Vidyashankar S, Varma RS, Patki PS. Quercetin ameliorate 
insulin resistance and up-regulates cellular antioxidants 
during oleic acid induced hepatic steatosis in HepG2 cells. 
Toxicol In Vitro. 2013;27(2):945–53.
https://doi.org/10.1016/j.tiv.2013.01.014
23.  Yin J, Luo Y, Deng H, Qin S, Tang W, Zeng L, Zhou B. Hugan 
Qingzhi medication ameliorates hepatic steatosis by acti-
vating AMPK and PPARα pathways in L02 cells and HepG2 
cells. J Ethnopharmacol. 2014;154(1):229–39.
https://doi.org/10.1016/j.jep.2014.04.011
24.  Ferrari E, Benassi R, Sacchi S, Pignedoli F, Asti M, Saladini M. 
Curcumin derivatives as metal-chelating agents with po-
tential multifunctional activity for pharmaceutical applica-
tions. J Inorg Biochem. 2014;139:38–48.
https://doi.org/10.1016/j.jinorgbio.2014.06.002
25.  Zhang Y, Dai B, Deng Y, Zhao Y. In vitro anti-inflammatory 
and antioxidant activities and protein quality of high hy-
drostatic pressure treated squids (Todarodes pacificus). 
Food Chem. 2016;203:258–66.
https://doi.org/10.1016/j.foodchem.2016.02.072
26.  Cai S, Huang C, Ji B, Zhou F, Wise ML, Zhang D, Yang P. In 
vitro antioxidant activity and inhibitory effect, on oleic ac-
id-induced hepatic steatosis, of fractions and subfractions 
from oat (Avena sativa L.) ethanol extract. Food Chem. 
2011;124(3):900–5.
https://doi.org/10.1016/j.foodchem.2010.07.017
27.  Zhang D, Xie L, Jia G, Cai S, Ji B, Liu Y, et al. Comparative 
study on antioxidant capacity of flavonoids and their inhib-
itory effects on oleic acid-induced hepatic steatosis in vitro. 
Eur J Med Chem. 2011;46(9):4548–58.
https://doi.org/10.1016/j.ejmech.2011.07.031 
